These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21186112)

  • 1. Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart.
    Angelone T; Filice E; Quintieri AM; Imbrogno S; Amodio N; Pasqua T; Pellegrino D; Mulè F; Cerra MC
    Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):486-94. PubMed ID: 21186112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
    Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
    Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postconditioning with glucagon like peptide-2 reduces ischemia/reperfusion injury in isolated rat hearts: role of survival kinases and mitochondrial KATP channels.
    Penna C; Pasqua T; Perrelli MG; Pagliaro P; Cerra MC; Angelone T
    Basic Res Cardiol; 2012 Jul; 107(4):272. PubMed ID: 22699364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
    Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
    J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
    Widmann C; Dolci W; Thorens B
    Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas.
    de Heer J; Pedersen J; Orskov C; Holst JJ
    Diabetologia; 2007 Oct; 50(10):2135-42. PubMed ID: 17676310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells.
    Lovshin JA; Huang Q; Seaberg R; Brubaker PL; Drucker DJ
    Endocrinology; 2004 Jul; 145(7):3495-506. PubMed ID: 15059959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes.
    Vila Petroff MG; Egan JM; Wang X; Sollott SJ
    Circ Res; 2001 Aug; 89(5):445-52. PubMed ID: 11532906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids.
    Abrahamsen N; Nishimura E
    Endocrinology; 1995 Apr; 136(4):1572-8. PubMed ID: 7534705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism.
    Nyström T; Gonon AT; Sjöholm A; Pernow J
    Regul Pept; 2005 Feb; 125(1-3):173-7. PubMed ID: 15582729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 does not mediate amylase release from AR42J cells.
    Zhou J; Montrose-Rafizadeh C; Janczewski AM; Pineyro MA; Sollott SJ; Wang Y; Egan JM
    J Cell Physiol; 1999 Dec; 181(3):470-8. PubMed ID: 10528233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 inhibits structural remodeling and improves Ca
    Chen J; Wang D; Wang F; Shi S; Chen Y; Yang B; Tang Y; Huang C
    Peptides; 2017 Apr; 90():69-77. PubMed ID: 28242257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor.
    Nuche-Berenguer B; Portal-Núñez S; Moreno P; González N; Acitores A; López-Herradón A; Esbrit P; Valverde I; Villanueva-Peñacarrillo ML
    J Cell Physiol; 2010 Nov; 225(2):585-92. PubMed ID: 20506394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of phospholamban phosphorylation and S-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart.
    Filice E; Angelone T; De Francesco EM; Pellegrino D; Maggiolini M; Cerra MC
    Cell Physiol Biochem; 2011; 28(1):41-52. PubMed ID: 21865847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways.
    Koehler JA; Yusta B; Drucker DJ
    Mol Endocrinol; 2005 Feb; 19(2):459-73. PubMed ID: 15471943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.
    Serre V; Dolci W; Schaerer E; Scrocchi L; Drucker D; Efrat S; Thorens B
    Endocrinology; 1998 Nov; 139(11):4448-54. PubMed ID: 9794451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa.
    Walsh NA; Yusta B; DaCambra MP; Anini Y; Drucker DJ; Brubaker PL
    Endocrinology; 2003 Oct; 144(10):4385-92. PubMed ID: 12960094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.
    Schepp W; Dehne K; Riedel T; Schmidtler J; Schaffer K; Classen M
    Digestion; 1996; 57(6):398-405. PubMed ID: 8913701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.